• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. It develops a discovery platform called StemScreen, which identifies novel compounds that target and kill cancer stem cells. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.
Market Cap | 595.937 Million | Shares Outstanding | 50.375 Million | Avg 30-day Volume | 1.99 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.55 |
Price to Revenue | 5.4028 | Debt to Equity | 0.0 | EBITDA | -73.214 Million |
Price to Book Value | 1.7214 | Operating Margin | -155.51489999999998 | Enterprise Value | 102.629 Million |
Current Ratio | 7.429 | EPS Growth | 0.488 | Quick Ratio | 7.18 |
1 Yr BETA | 1.0509 | 52-week High/Low | 0.0 / | Profit Margin | -150.3021 |
Operating Cash Flow Growth | 23.1859 | Altman Z-Score | 3.3518 | Free Cash Flow to Firm | -62.793 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
No longer subject to file | 2020-06-10 | 0 | |
|
No longer subject to file | 2020-06-10 | 0 | |
|
No longer subject to file | 2020-06-10 | 0 | |
GIONCO DAVID CHIEF ACCOUNTING OFFICER |
|
No longer subject to file | 2020-06-10 | 0 |
BERGSTEIN IVAN CHIEF EXECUTIVE OFFICER |
|
No longer subject to file | 2020-06-10 | 0 |
HOBERMAN KENNETH CHIEF OPERATING OFFICER |
|
No longer subject to file | 2020-06-10 | 0 |
|
No longer subject to file | 2020-06-10 | 0 | |
|
No longer subject to file | 2020-06-10 | 0 | |
|
No longer subject to file | 2020-06-10 | 0 | |
FRANCOMANO ROBERT CHIEF COMMERCIAL OFFICER |
|
No longer subject to file | 2020-06-10 | 0 |
BERGSTEIN IVAN CHIEF EXECUTIVE OFFICER BERGSTEIN IVAN CHIEF EXECUTIVE OFFICER |
|
2,726,151 | 2019-02-25 | 0 |
|
27,963 | 2017-06-19 | 0 | |
|
23,772 | 2015-06-23 | 0 | |
ROWINSKY ERIC K CHIEF MEDICAL OFFICER |
|
143,688 | 2015-04-27 | 0 |
HALL STEPHEN P CHIEF ACCOUNTING OFFICER |
|
40,000 | 2013-06-19 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|